Cargando…
The epigenetic function of androgen receptor in prostate cancer progression
Androgen and androgen deprivation (castration) therapies, including androgen receptor antagonists, are clinically used to treat patients with prostate cancer. However, most hormone-dependent prostate cancer patients progress into a malignant state with loss of hormone-dependency, known as castration...
Autores principales: | Sawada, Takahiro, Kanemoto, Yoshiaki, Kurokawa, Tomohiro, Kato, Shigeaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070878/ https://www.ncbi.nlm.nih.gov/pubmed/37025180 http://dx.doi.org/10.3389/fcell.2023.1083486 |
Ejemplares similares
-
Androgen Receptor-Related Non-coding RNAs in Prostate Cancer
por: Yang, Yongyong, et al.
Publicado: (2021) -
Profiling of Androgen-Dependent Enhancer RNAs Expression in Human Prostate Tumors: Search for Malignancy Transition Markers
por: Nishimura, Koichi, et al.
Publicado: (2021) -
The Role of Androgen Receptor in Cross Talk Between Stromal Cells and Prostate Cancer Epithelial Cells
por: Tang, Qianyao, et al.
Publicado: (2021) -
Androgen-Driven Fusion Genes and Chimeric Transcripts in Prostate Cancer
por: Scaravilli, Mauro, et al.
Publicado: (2021) -
Tumor Suppressive Maspin-Sensitized Prostate Cancer to Drug Treatment Through Negative Regulating Androgen Receptor Expression
por: Tang, Sijie, et al.
Publicado: (2020)